Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 126

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 126
---
 Company may also need to raise capital from equity and debt financings.

Cash flows

The following table sets forth summary of our cash flows for the years ended March 31, 2024 and 2023, respectively.

|                                         |     | For the years 
 ended         
 March         
 31,           |      2024 |   |     |   |       2023 |   |
|:----------------------------------------|:----|:--------------|----------:|:--|:----|:--|-----------:|:--|
| Net cash generated from operating       
 activities                              |     | $             |   687,495 |   |     | $ |  1,403,676 |   |
| Net cash used in investing activities   |     |               |         - |   |     |   |          - |   |
| Net cash used in financing              
 activities                              |     |               |  (574,414 | ) |     |   | (3,224,882 | ) |
| Net increase (decrease) in cash         |     |               |   113,081 |   |     |   | (1,821,206 | ) |
| Effect of exchange rate changes on cash |     |               |     6,655 |   |     |   |     (8,473 | ) |
| Cash and cash equivalents               
 at the beginning of the year            |     |               | 2,195,190 |   |     |   |  4,024,869 |   |
| Cash and cash equivalents               
 at the end of the year                  |     | $             | 2,314,926 |   |     | $ |  2,195,190 |   |

Net cash generated from operating activities

Net cash generated from operating activities was $687,495 and $1,403,676 for the years ended March 31, 2024 and 2023, respectively. When comparing fiscal year 2024 with fiscal year 2023:

For the year ended March 31, 2024, our net cash generated from operating activities was $687,495, which was primarily derived from (i) net income of $753,429 and adjusted for non-cash depreciation of $86,321; (ii) decrease in prepayment to suppliers by $149,211 as products ordered has delivered during the year; while partially offset by (i) increase in inventories by $225,073 as the